Corrigendum to "Metabolic plasticity and optimal redox homeostasis are essential for efficient metastatic colonization" [Mol Metab 109 (2026) 102382/42155637].
Saved in:
| Title: | Corrigendum to "Metabolic plasticity and optimal redox homeostasis are essential for efficient metastatic colonization" [Mol Metab 109 (2026) 102382/42155637]. |
|---|---|
| Authors: | Grace E; Department of Experimental Medicine 1, Nikolaus-Fiebiger Center for Molecular Medicine, Friedrich-Alexander University of Erlangen-Nürnberg (FAU), Erlangen, Germany., Zou D; Department of Hematology, Oncology and Cell Therapy, Otto-von-Guericke-University of Magdeburg, Magdeburg, Germany., Böttcher-Loschinski R; Department of Hematology, Oncology and Cell Therapy, Otto-von-Guericke-University of Magdeburg, Magdeburg, Germany; Magdeburg Centre for Cell and Immune Therapy (MAZI), Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany., Böttcher M; Department of Hematology, Oncology and Cell Therapy, Otto-von-Guericke-University of Magdeburg, Magdeburg, Germany; Magdeburg Centre for Cell and Immune Therapy (MAZI), Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany; Healthcampus Immunology, Inflammation and Infectiology (GC-I3), Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany., Schuhwerk H; Department of Experimental Medicine 1, Nikolaus-Fiebiger Center for Molecular Medicine, Friedrich-Alexander University of Erlangen-Nürnberg (FAU), Erlangen, Germany; Department of Dermatology, University Hospital Regensburg, Regensburg, Germany., Hajjaj Y; Department of Experimental Medicine 1, Nikolaus-Fiebiger Center for Molecular Medicine, Friedrich-Alexander University of Erlangen-Nürnberg (FAU), Erlangen, Germany., Schwab A; Department of Experimental Medicine 1, Nikolaus-Fiebiger Center for Molecular Medicine, Friedrich-Alexander University of Erlangen-Nürnberg (FAU), Erlangen, Germany., Brandt S; Department of Experimental Medicine 1, Nikolaus-Fiebiger Center for Molecular Medicine, Friedrich-Alexander University of Erlangen-Nürnberg (FAU), Erlangen, Germany., Ezquerra AC; Department of Experimental Medicine 1, Nikolaus-Fiebiger Center for Molecular Medicine, Friedrich-Alexander University of Erlangen-Nürnberg (FAU), Erlangen, Germany., Szymanski W; Institute of Translational Proteomics & Core Facility Translational Proteomics, Philipps-Universität Marburg, Marburg, Germany., Graumann J; Institute of Translational Proteomics & Core Facility Translational Proteomics, Philipps-Universität Marburg, Marburg, Germany., Arnold P; Institute of Functional and Clinical Anatomy, University Hospital Erlangen, Friedrich-Alexander University of Erlangen-Nürnberg (FAU), Erlangen, Germany., Liguori R; Department of Experimental Medicine 1, Nikolaus-Fiebiger Center for Molecular Medicine, Friedrich-Alexander University of Erlangen-Nürnberg (FAU), Erlangen, Germany; Department of Nephropathology, Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander University of Erlangen-Nürnberg (FAU), Erlangen, Germany; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander University of Erlangen-Nürnberg (FAU), Erlangen, Germany., Ferrazzi F; Department of Nephropathology, Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander University of Erlangen-Nürnberg (FAU), Erlangen, Germany; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander University of Erlangen-Nürnberg (FAU), Erlangen, Germany; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Bavarian Cancer Research Center (BZKF), Erlangen, Germany., Krempe CP; Department of Dermatology, University Hospital Essen, German Cancer Consortium (DKTK) and Research Alliance Ruhr, Research Center One Health, Campus Essen, Essen, Germany; Applied Analytical Chemistry, University of Duisburg-Essen, Essen, Germany., Nascentes Melo LM; Department of Dermatology, University Hospital Essen, German Cancer Consortium (DKTK) and Research Alliance Ruhr, Research Center One Health, Campus Essen, Essen, Germany., Allies G; Department of Dermatology, University Hospital Essen, German Cancer Consortium (DKTK) and Research Alliance Ruhr, Research Center One Health, Campus Essen, Essen, Germany., Meckelmann SW; Applied Analytical Chemistry, University of Duisburg-Essen, Essen, Germany., Mielenz D; Department of Translational Immunology, Department of Internal Medicine 3, University Hospital Erlangen, Friedrich-Alexander University of Erlangen-Nürnberg (FAU), Erlangen, Germany., Brabletz S; Department of Experimental Medicine 1, Nikolaus-Fiebiger Center for Molecular Medicine, Friedrich-Alexander University of Erlangen-Nürnberg (FAU), Erlangen, Germany; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Bavarian Cancer Research Center (BZKF), Erlangen, Germany., Mougiakakos D; Department of Hematology, Oncology and Cell Therapy, Otto-von-Guericke-University of Magdeburg, Magdeburg, Germany; Magdeburg Centre for Cell and Immune Therapy (MAZI), Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany; Healthcampus Immunology, Inflammation and Infectiology (GC-I3), Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany; Center for Health and Medical Prevention - CHAMP, Otto-von-Guericke University, Magdeburg, Germany., Tasdogan A; Department of Dermatology, University Hospital Essen, German Cancer Consortium (DKTK) and Research Alliance Ruhr, Research Center One Health, Campus Essen, Essen, Germany., Brabletz T; Department of Experimental Medicine 1, Nikolaus-Fiebiger Center for Molecular Medicine, Friedrich-Alexander University of Erlangen-Nürnberg (FAU), Erlangen, Germany; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Bavarian Cancer Research Center (BZKF), Erlangen, Germany., Stemmler MP; Department of Experimental Medicine 1, Nikolaus-Fiebiger Center for Molecular Medicine, Friedrich-Alexander University of Erlangen-Nürnberg (FAU), Erlangen, Germany. Electronic address: marc.stemmler@fau.de. |
| Source: | Molecular metabolism [Mol Metab] 2026 Aug; Vol. 110, pp. 102401. Date of Electronic Publication: 2026 Jun 18. |
| Publication Type: | Published Erratum |
| Journal Info: | Publisher: Elsevier GmbH Country of Publication: Germany NLM ID: 101605730 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2212-8778 (Electronic) Linking ISSN: 22128778 NLM ISO Abbreviation: Mol Metab Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
